Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's disease
(Q64768959)
scientific article published on 01 January 1983
scientific article published on 01 January 1983
Language:
Current Data About
Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's disease